ATE361760T1 - Verbesserungen in der bereitung von prodrogen - Google Patents
Verbesserungen in der bereitung von prodrogenInfo
- Publication number
- ATE361760T1 ATE361760T1 AT94921729T AT94921729T ATE361760T1 AT E361760 T1 ATE361760 T1 AT E361760T1 AT 94921729 T AT94921729 T AT 94921729T AT 94921729 T AT94921729 T AT 94921729T AT E361760 T1 ATE361760 T1 AT E361760T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- ftli
- sec
- prt
- date
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939315494A GB9315494D0 (en) | 1993-07-27 | 1993-07-27 | Improvements relating to prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE361760T1 true ATE361760T1 (de) | 2007-06-15 |
Family
ID=10739484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94921729T ATE361760T1 (de) | 1993-07-27 | 1994-07-27 | Verbesserungen in der bereitung von prodrogen |
Country Status (12)
Country | Link |
---|---|
US (1) | US5770731A (de) |
EP (1) | EP0711177B1 (de) |
JP (1) | JPH09500896A (de) |
KR (1) | KR960703623A (de) |
AT (1) | ATE361760T1 (de) |
AU (1) | AU693799B2 (de) |
CA (1) | CA2167480A1 (de) |
DE (1) | DE69434970T2 (de) |
GB (1) | GB9315494D0 (de) |
HU (1) | HUT73979A (de) |
NZ (1) | NZ268934A (de) |
WO (1) | WO1995003830A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9415167D0 (en) | 1994-07-27 | 1994-09-14 | Springer Caroline J | Improvements relating to cancer therapy |
GB9501052D0 (en) * | 1995-01-19 | 1995-03-08 | Cancer Res Campaign Tech | Improvements relating to prodrugs |
GB9601640D0 (en) * | 1996-01-26 | 1996-03-27 | Cancer Res Campaign Tech | Ligand directed enzyme prodrug therapy |
US6656718B2 (en) | 2000-07-07 | 2003-12-02 | Cancer Research Technology Limited | Modified carboxypeptidase enzymes and their use |
ES2358730T3 (es) | 2002-07-15 | 2011-05-13 | Board Of Regents, The University Of Texas System | Anticuerpos seleccionados y péptidos de duramicina que se enlazan a fosfolípidos aniónicos y aminofosfolípidos y sus usos en el tratamiento de infecciones virales y del cáncer. |
GB0220319D0 (en) | 2002-09-02 | 2002-10-09 | Cancer Res Campaign Tech | Enzyme activated self-immolative nitrogen mustard drugs |
ES2572356T3 (es) | 2007-11-09 | 2016-05-31 | Peregrine Pharmaceuticals Inc | Composiciones de anticuerpos dirigidos contra VEGF y procedimientos |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB915454A (en) * | 1960-06-28 | 1963-01-16 | Nat Res Dev | Nitrogen mustards |
US5340828A (en) * | 1991-09-30 | 1994-08-23 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
US5238922A (en) * | 1991-09-30 | 1993-08-24 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
DE69233669T2 (de) * | 1991-10-23 | 2007-10-25 | Cancer Research Technology Ltd. | Bakterielle nitroreduktase zur reduzierung von cb 1954 und analogen davon in eine zytotoxische form |
US5245061A (en) * | 1991-12-16 | 1993-09-14 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
US5260479A (en) * | 1991-12-16 | 1993-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
US5420157A (en) * | 1991-12-16 | 1995-05-30 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase or prodrugs thereof |
GB2264492B (en) * | 1992-02-27 | 1996-09-25 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
GB9314960D0 (en) * | 1992-07-23 | 1993-09-01 | Zeneca Ltd | Chemical compounds |
WO1995002420A2 (en) * | 1993-07-15 | 1995-01-26 | Cancer Research Campaign Technology Ltd. | Prodrugs of protein tyrosine kinase inhibitors |
-
1993
- 1993-07-27 GB GB939315494A patent/GB9315494D0/en active Pending
-
1994
- 1994-02-27 KR KR1019960700377A patent/KR960703623A/ko not_active Application Discontinuation
- 1994-07-27 CA CA002167480A patent/CA2167480A1/en not_active Abandoned
- 1994-07-27 NZ NZ268934A patent/NZ268934A/en unknown
- 1994-07-27 AU AU72333/94A patent/AU693799B2/en not_active Ceased
- 1994-07-27 WO PCT/GB1994/001610 patent/WO1995003830A2/en active IP Right Grant
- 1994-07-27 US US08/586,637 patent/US5770731A/en not_active Expired - Fee Related
- 1994-07-27 JP JP7505647A patent/JPH09500896A/ja active Pending
- 1994-07-27 HU HU9503984A patent/HUT73979A/hu unknown
- 1994-07-27 EP EP94921729A patent/EP0711177B1/de not_active Expired - Lifetime
- 1994-07-27 AT AT94921729T patent/ATE361760T1/de not_active IP Right Cessation
- 1994-07-27 DE DE69434970T patent/DE69434970T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU693799B2 (en) | 1998-07-09 |
US5770731A (en) | 1998-06-23 |
KR960703623A (ko) | 1996-08-31 |
HUT73979A (en) | 1996-10-28 |
DE69434970T2 (de) | 2008-01-31 |
DE69434970D1 (de) | 2007-06-21 |
EP0711177B1 (de) | 2007-05-09 |
WO1995003830A3 (en) | 1995-04-06 |
JPH09500896A (ja) | 1997-01-28 |
GB9315494D0 (en) | 1993-09-08 |
WO1995003830A2 (en) | 1995-02-09 |
NZ268934A (en) | 1997-12-19 |
HU9503984D0 (en) | 1996-03-28 |
EP0711177A1 (de) | 1996-05-15 |
AU7233394A (en) | 1995-02-28 |
CA2167480A1 (en) | 1995-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9106819A (pt) | Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos | |
ATE249466T1 (de) | Silizium enthaltender kettenverlängerer | |
DK0941218T3 (da) | Antithrombotiske organiske nitrater | |
MX9307052A (es) | Derivados del taxano sustituidos con furil-carbonilo o tienil-carbonilo y composiciones farmaceuticas que los contienen. | |
PL339701A1 (en) | Acylosulphamoybenzamides, crop protection products containing them and method of obtaining such crop protection products | |
ES2036562T3 (es) | Un procedimiento para produccion de un derivado de pirrolidinamida. | |
ATE205072T1 (de) | Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung | |
HUP9801387A2 (hu) | Antibakteriális cefalosporinszármazékok | |
DE69434970D1 (de) | Verbesserungen in der bereitung von prodrogen | |
ATE161717T1 (de) | Antivirale mittel | |
NO20004092D0 (no) | Cyklisk amidforbindelse | |
ATE260285T1 (de) | Geschützte phenylalkylsilane | |
HUP9802764A2 (hu) | Guanidino-proteáz-inhibitorok | |
ES2177816T3 (es) | Derivados de azahexano como isosteros de sustrato de aspartato proteasas retroviricas. | |
DE69017584D1 (de) | Pflanzenschutzzubereitungen, tierärztliche und zusätzliche herstellungen. | |
DE69623555D1 (de) | Inhibitor der krebsmetastasierung | |
FI940731A (fi) | Amiditetratsolit ACAT-inhibiitoreina | |
WO1998049998A3 (de) | Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen | |
FR2707496B1 (fr) | Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes. | |
NO994107L (no) | Preparater for behandling eller forhindring av prostatakreft | |
FR2707634B1 (fr) | Procédé de préparation de N-carbonylarylimines utiles dans la synthèse de taxoïdes thérapeutiquement actifs. | |
DE60144376D1 (de) | N und anwendungen | |
ES2164665T3 (es) | Inhibidores de proteasas retrovirales. | |
ATE252565T1 (de) | N,n'-disubstituierte n-(2-hydroxyalkyl)- harnstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |